单位(元)华安医疗创新混合C(013483)利润表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
收入 |
-102,293,517 |
-76,028,878 |
-130,036,609 |
-59,982,375 |
利息收入 |
437,636 |
251,047 |
464,377 |
219,449 |
其中:存款利息收入 |
437,636 |
251,047 |
464,377 |
219,449 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益 |
-77,974,660 |
-21,843,486 |
-172,286,213 |
-125,643,233 |
其中:股票投资收益 |
-84,859,635 |
-28,146,435 |
-177,245,977 |
-129,988,921 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
98,650 |
75,353 |
164,917 |
- |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
6,786,325 |
6,227,595 |
4,794,847 |
4,345,688 |
公允价值变动收益 |
-25,416,045 |
-55,000,468 |
40,168,540 |
64,490,276 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
659,551 |
564,028 |
1,616,688 |
951,133 |
费用 |
17,206,690 |
11,759,487 |
17,550,934 |
6,961,505 |
管理人报酬 |
13,675,325 |
9,293,642 |
13,983,546 |
5,638,970 |
托管费 |
2,279,221 |
1,548,940 |
2,330,591 |
939,828 |
销售服务费 |
976,818 |
763,243 |
950,782 |
247,679 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
275,326 |
153,662 |
286,015 |
135,027 |
利润总额 |
-119,500,207 |
-87,788,366 |
-147,587,543 |
-66,943,880 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
-119,500,207 |
-87,788,366 |
-147,587,543 |
-66,943,880 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。